Sanofi (NASDAQ:SNY) Releases Quarterly Earnings Results, Meets Expectations

Sanofi (NASDAQ:SNY) posted its quarterly earnings data on Thursday. The company reported $0.70 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.70, Zacks reports. Sanofi had a return on equity of 27.45% and a net margin of 9.96%.

Sanofi Price Performance

Shares of SNY opened at $54.15 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. The company has a 50 day moving average price of $49.12 and a 200-day moving average price of $52.24. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The stock has a market capitalization of $137.42 billion, a PE ratio of 27.63, a PEG ratio of 1.21 and a beta of 0.57.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SNY. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a report on Thursday. Two research analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.